retatrutide triple hormone receptor agonist metabolic obesity Agonism Based Therapies for | Current Cardiovascular Risk Reports Incretin triple agonist retatrutide (LY3437943)
Pay in 4 interest-free payments of $5.88 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 15 - Nov 20


























